353 related articles for article (PubMed ID: 29656849)
1. Association of highly active antiretroviral treatment with incident tuberculosis in people living with HIV/AIDS.
Yen YF; Jen IA; Chuang PH; Chen M; Lan YC; Lee CY; Arthur Chen YM
Ann Epidemiol; 2018 Dec; 28(12):886-892.e3. PubMed ID: 29656849
[TBL] [Abstract][Full Text] [Related]
2. Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.
Miranda A; Morgan M; Jamal L; Laserson K; Barreira D; Silva G; Santos J; Wells C; Paine P; Garrett D
PLoS One; 2007 Sep; 2(9):e826. PubMed ID: 17786198
[TBL] [Abstract][Full Text] [Related]
3. Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident Opportunistic Infections among People Living with HIV/AIDS.
Yen YF; Chen M; Jen IA; Chuang PH; Lee CY; Lin SI; Chen YA
Sci Rep; 2019 Mar; 9(1):3476. PubMed ID: 30837537
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?
Pettit AC; Jenkins CA; Stinnette SE; Rebeiro PF; Blackwell RB; Raffanti SP; Shepherd BE; Sterling TR
J Acquir Immune Defic Syndr; 2011 Aug; 57(4):305-10. PubMed ID: 21423024
[TBL] [Abstract][Full Text] [Related]
5. Human Immunodeficiency Virus Infection Increases the Risk of Incident Uveitis Among People Living With HIV/AIDS.
Yen YF; Feng JY; Yi-Fong Su V; Chuang PH; Ko MC; Chen CC; Li YJ; Pan SW; Su WJ
J Acquir Immune Defic Syndr; 2018 Oct; 79(2):149-157. PubMed ID: 30212432
[TBL] [Abstract][Full Text] [Related]
6. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
Golub JE; Pronyk P; Mohapi L; Thsabangu N; Moshabela M; Struthers H; Gray GE; McIntyre JA; Chaisson RE; Martinson NA
AIDS; 2009 Mar; 23(5):631-6. PubMed ID: 19525621
[TBL] [Abstract][Full Text] [Related]
7. Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia.
Kassa A; Teka A; Shewaamare A; Jerene D
Trans R Soc Trop Med Hyg; 2012 Jun; 106(6):363-70. PubMed ID: 22521216
[TBL] [Abstract][Full Text] [Related]
8. Human Immunodeficiency Virus Increases the Risk of Incident Heart Failure.
Yen YF; Ko MC; Yen MY; Hu BS; Wang TH; Chuang PH; Lai HH; Chen CC; Deng CY
J Acquir Immune Defic Syndr; 2019 Mar; 80(3):255-263. PubMed ID: 30531301
[TBL] [Abstract][Full Text] [Related]
9. Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso.
Dembélé M; Saleri N; Carvalho AC; Saouadogo T; Hien AD; Zabsonre I; Koala ST; Simporé J; Matteelli A
Int J Tuberc Lung Dis; 2010 Mar; 14(3):318-23. PubMed ID: 20132623
[TBL] [Abstract][Full Text] [Related]
10. Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count.
Martín-Echevarria E; Rodríguez-Zapata M; Torralba M; Fernández JM; Moreno A; Casado JL; Dronda F; Pérez-Elías MJ; Navas E; Moreno S
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1347-52. PubMed ID: 22283893
[TBL] [Abstract][Full Text] [Related]
11. Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India.
Dravid A; Natarajan K; Medisetty M; Gawali R; Mahajan U; Kulkarni M; Saraf C; Ghanekar C; Kore S; Rathod N; Dravid M
BMC Infect Dis; 2019 Aug; 19(1):714. PubMed ID: 31409289
[TBL] [Abstract][Full Text] [Related]
12. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.
Braitstein P; Nyandiko W; Vreeman R; Wools-Kaloustian K; Sang E; Musick B; Sidle J; Yiannoutsos C; Ayaya S; Carter EJ
Pediatr Infect Dis J; 2009 Jul; 28(7):626-32. PubMed ID: 19451858
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW
AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295
[TBL] [Abstract][Full Text] [Related]
14. A Clinical Algorithm to Identify HIV Patients at High Risk for Incident Active Tuberculosis: A Prospective 5-Year Cohort Study.
Lee SS; Lin HH; Tsai HC; Su IJ; Yang CH; Sun HY; Hung CC; Sy CL; Wu KS; Chen JK; Chen YS; Fang CT
PLoS One; 2015; 10(8):e0135801. PubMed ID: 26280669
[TBL] [Abstract][Full Text] [Related]
15. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.
Hung CC; Chen MY; Hsiao CF; Hsieh SM; Sheng WH; Chang SC
AIDS; 2003 Dec; 17(18):2615-22. PubMed ID: 14685055
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
Semu M; Fenta TG; Medhin G; Assefa D
BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial.
Amogne W; Aderaye G; Habtewold A; Yimer G; Makonnen E; Worku A; Sonnerborg A; Aklillu E; Lindquist L
PLoS One; 2015; 10(5):e0122587. PubMed ID: 25966339
[TBL] [Abstract][Full Text] [Related]
18. HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort.
Martinson NA; Moultrie H; van Niekerk R; Barry G; Coovadia A; Cotton M; Violari A; Gray GE; Chaisson RE; McIntyre JA; Meyers T
Int J Tuberc Lung Dis; 2009 Jul; 13(7):862-7. PubMed ID: 19555536
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.
Seyler C; Toure S; Messou E; Bonard D; Gabillard D; Anglaret X
Am J Respir Crit Care Med; 2005 Jul; 172(1):123-7. PubMed ID: 15805184
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.
Lawn SD; Badri M; Wood R
AIDS; 2005 Dec; 19(18):2109-16. PubMed ID: 16284460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
